Loading...
Trial Watch: Chemotherapy with immunogenic cell death inducers
Accumulating evidence suggests that the clinical efficacy of selected anticancer drugs, including conventional chemotherapeutics as well as targeted anticancer agents, originates (at least in part) from their ability to elicit a novel or reinstate a pre-existing tumor-specific immune response. One o...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4008470/ https://ncbi.nlm.nih.gov/pubmed/24800173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27878 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|